Evidence map›Paper›PMID 41312125›Full record

ArticleComputational and structural biotechnology journal2025

Multi-matrix metabolomics in rare monogenic diabetes syndromes: Analysis of oral fluids and serum in carriers of pathogenic variants in the

Ewa Zmysłowska-Polakowska, Patrycja Mojsak, Sebastian Skoczylas, Krzysztof Sołowiej, Sandra Chmielewska, Julia Grzybowska-Adamowicz, Aleksandra Palatynska-Ulatowska, Monika Lukomska-Szymanska, Adam Kretowski, Agnieszka Zmysłowska and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ewa Zmysłowska-PolakowskaDepartment of Endodontics, Medical University of Lodz, Lodz, Poland.
Patrycja MojsakClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Sebastian SkoczylasDepartment of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
Krzysztof SołowiejClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Sandra ChmielewskaClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Julia Grzybowska-AdamowiczDepartment of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
Aleksandra Palatynska-UlatowskaDepartment of Endodontics, Medical University of Lodz, Lodz, Poland.
Monika Lukomska-SzymanskaDepartment of General Dentistry, Medical University of Lodz, Lodz, Poland.
Adam KretowskiClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Agnieszka ZmysłowskaDepartment of Clinical Genetics, Medical University of Lodz, Lodz, Poland.
Michał CiborowskiClinical Research Centre, Medical University of Bialystok, Bialystok, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolomic profiling enables the identification of specific biochemical alterations in various diseases, including rare monogenic diabetes and obesity syndromes such as Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS). These disorders are characterized by early-onset obesity, insulin resistance, diabetes mellitus, retinodystrophy and other symptoms, but some features may also occur in heterozygous carriers of pathogenic or likely pathogenic variants in

Indexed as

Alström syndromeBardet–Biedl syndromeheterozygous carriersoral metabolomics

Identifiers

PMID41312125
PMCPMC12648480

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.